Page last updated: 2024-10-21

3-aminobenzamide and Fibrosis

3-aminobenzamide has been researched along with Fibrosis in 1 studies

Fibrosis: Any pathological condition where fibrous connective tissue invades any organ, usually as a consequence of inflammation or other injury.

Research Excerpts

ExcerptRelevanceReference
"Fibrosis is one of the major pathological features of hypertensive vascular disease."5.39Inhibition of PARP prevents angiotensin II-induced aortic fibrosis in rats. ( Deng, S; Huang, D; Huang, K; Wang, L; Wang, R; Wang, Y; Zhang, C; Zhang, F; Zhang, Y, 2013)
"Fibrosis is one of the major pathological features of hypertensive vascular disease."1.39Inhibition of PARP prevents angiotensin II-induced aortic fibrosis in rats. ( Deng, S; Huang, D; Huang, K; Wang, L; Wang, R; Wang, Y; Zhang, C; Zhang, F; Zhang, Y, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wang, Y1
Wang, L1
Zhang, F1
Zhang, C1
Deng, S1
Wang, R1
Zhang, Y1
Huang, D1
Huang, K1

Other Studies

1 other study available for 3-aminobenzamide and Fibrosis

ArticleYear
Inhibition of PARP prevents angiotensin II-induced aortic fibrosis in rats.
    International journal of cardiology, 2013, Sep-01, Volume: 167, Issue:5

    Topics: Angiotensin II; Animals; Aorta, Thoracic; Benzamides; Cells, Cultured; Enzyme Inhibitors; Fibrosis;

2013